Skip to main content
KPC PHARMACEUTICALS, INC. logo

KPC PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · 600422 ISIN · CNE0000015P8 LEI · 3003007ZALHXKUFMKN96 Shanghai Stock Exchange Manufacturing
Filings indexed 2,727 across all filing types
Latest filing 2015-12-23 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600422

About KPC PHARMACEUTICALS, INC.

https://en.kpc.com.cn/

KPC Pharmaceuticals, Inc. specializes in the research, development, and manufacturing of pharmaceutical products, with a significant focus on natural and botanical medicines. The company is a global leader in the production of artemisinin-based anti-malarial treatments, including artemether and its derivatives. Its portfolio encompasses a wide range of therapeutic areas, notably cardiovascular and cerebrovascular health, where it utilizes Panax notoginseng saponins as a core component. KPC integrates traditional medicinal knowledge with modern pharmacological techniques to develop standardized botanical extracts and chemical drugs. The organization operates extensive production facilities and research centers dedicated to drug discovery and quality control. Its business activities extend to the distribution of healthcare products and the provision of medical services, aiming to provide comprehensive health solutions through innovation in natural medicine and biotechnology.

Recent filings

Filing Released Lang Actions
关于昆明贝克诺顿制药有限公司49%股权收购完成的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of the acquisition of 49% equity in a subsidiary company, Kunming Becknorton Pharmaceutical Co., Ltd. It details the transaction steps, payment completion, and future plans for further acquisition. The content focuses on a capital transaction and ownership change rather than financial results, management changes, or regulatory filings. The document length is short (901 characters) and it is a formal announcement of a financing/capital transaction. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-12-23 Chinese
八届三次董事会决议公告
Board/Management Information Classification · 95% confidence The document is a board resolution announcement from Kunming Pharmaceutical Group Co., Ltd. It details decisions made at the company's eighth board meeting, including acquisitions of subsidiaries' equity, establishment of a joint venture, and land use rights agreements. The document includes voting results and authorizations by the board. There is no financial data or report content, but rather formal announcements of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2015-12-22 Chinese
关于控股股东部分股权质押的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the pledge of shares by a controlling shareholder as collateral for a loan. It includes details about the number of shares pledged, the percentage of total shares, and the purpose of the pledge. There is no financial report, earnings data, or management discussion. The document is an official announcement about a financing-related event (share pledge) but does not detail a financing transaction like a new capital raise or issuance. It fits best under Capital/Financing Update (CAP) as it informs about a financing-related share pledge.
2015-12-18 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of the information disclosure obligor (云南合和(集团)股份有限公司) in the listed company (昆药集团股份有限公司). The document includes information about the nature of the shareholding change, the legal basis, approvals, and the specifics of the share transfer. It does not contain financial statements or earnings data but focuses on the change in ownership stakes. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is over 5,000 characters and contains detailed information about the shareholding change, not just an announcement or a brief note. Therefore, the correct classification is MRQ with high confidence.
2015-12-14 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the change in shareholding of the information disclosure obligor (云南红塔集团有限公司) in the listed company (昆药集团股份有限公司). The document includes specifics about the shareholding before and after the change, the method of change (state-owned equity administrative transfer), approvals, and legal compliance statements. It does not contain financial statements or earnings data but focuses on the change in share ownership and related disclosures. This matches the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document is over 5,000 characters and contains detailed information about the shareholding change, not just an announcement or a brief note. Therefore, the correct classification is MRQ with high confidence.
2015-12-10 Chinese
关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding a change in shareholder equity due to an absorption merger between two shareholders of the company. It details the transfer of shares from one shareholder to another without change in controlling interest. The document is short (1426 characters) and serves as a notification of a shareholder equity change rather than a detailed financial report or regulatory filing. It does not contain financial statements, audit information, or management discussion. It is not a voting result, board change, or capital financing update. The content fits best with a Major Shareholding Notification (MRQ) as it reports a significant change in share ownership levels (7.61% shares transferred).
2015-12-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.